ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo

Affiliations

• ¹ The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.
• ² Division of Oncology, Department of Medicine, Stanford University, California, 94305, USA.
• ³ Cancer Epigenetic Biology and Therapeutics Laboratory, Children's Cancer Institute, Randwick, NSW, 2052, Australia.
• ⁴ School of Women's and Children's Health, Faculty of Medicine, University of New South Wales Sydney, NSW, 2052, Australia.
• ⁵ Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, The University of Technology Sydney, Ultimo, NSW, 2007, Australia.
• ⁶ Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, California, 94305, USA.
• ⁷ Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, 5000, Australia.
• ⁸ School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, NSW, 2007, Australia.
• ⁹ Department of Anatomical Pathology, NSW Health Pathology, St George Hospital, Kogarah, NSW, 2217, Australia.
• ¹⁰ St George & Sutherland Clinical School, UNSW Sydney, NSW, 2217, Australia.
• ¹¹ Centre for Cancer Research, University of Melbourne, Parkville, VIC, 3010, Australia.
• ¹² School of Mechanical Engineering, University of Leeds, LS2 9JT, UK.
• ¹³ Department of Engineering Sciences and Mathematics, Luleå University of Technology, Luleå, 97187, Sweden.
• ¹⁴ St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, NSW, 2010, Australia.
• ¹⁵ Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, 5000, Australia.
• ¹⁶ Single Cell Core, Systems Biology, Harvard Medical School, Harvard University, Massachusetts, 02115, USA.